NOVARTIS AG (NVSEF)
Clinical trial NCT06004661 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-17 → 2026-12-14 3. primary completion date: 2026-06-17 → 2026-12-14 4. enrollment: 20 → 23 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical